JointMedica’s Polymotion Hip Resurfacing System Designated a Breakthrough Device

JointMedica’s Polymotion hip resurfacing system has been designated a Breakthrough Device by the FDA.

The breakthrough designation for the UK firm was announced by Gainesville, Fla.-based Exactech, a developer of implants, instrumentation and smart technologies for joint replacement surgery, which has exclusive global distribution rights to the product.

The Polymotion system is intended for “an acute unmet need of relatively younger, active hip arthritis patients,” JointMedica said. The device features metal-on-vitamin E crosslinked polyethylene hip resurfacing. Vitamin E is an antioxidant that has a protective effect on metals.

The Polymotion system “will complement Exactech’s Alteon hip arthroplasty portfolio,” said Exactech CEO Jeff Binder.